Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction

Gene Therapy

Volumn 20, Issue 12, 2013, Pages 1158-1164

  Parker, A L ^a,d   White, K M ^a   Lavery, C A ^a   Custers, J ^b   Waddington, S N ^c   Baker, A H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CRUCELL HOLLAND BV   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

adenovirus; CD46 receptor; coronary artery bypass grafting; coxsackie and adenovirus receptor; neointima; vascular smooth muscle cell

Indexed keywords

ADENOVIRUS VECTOR; MEMBRANE COFACTOR PROTEIN;

ADENOVIRUS 5; ARTICLE; CONTROLLED STUDY; EX VIVO GENE TRANSFER; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PSEUDOTYPING; SEROTYPE; SMOOTH MUSCLE FIBER; VIRUS CAPSID;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5; MIRIDAE;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIGENS, CD46; AORTA; CAPSID; CAPSID PROTEINS; CELLS, CULTURED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; COXSACKIE AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; TRANSDUCTION, GENETIC;

EID: 84890120446     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2013.44     Document Type: Article

References (31)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012; 125: E2-e220.
2. Hata M, Sezai A, Niino T, Yoda M, Wakui S, Chiku M et al. What is the optimal management for preventing saphenous vein graft diseases?: Early results of intravascular angioscopic assessment. Circ J 2007; 71: 286-287.
3. Wan S, George SJ, Nicklin SA, Yim AP, Baker AH. Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts. Mol Ther 2004; 9: 689-698.
4. Kritz AB, Yu J, Wright PL, Wan S, George SJ, Halliday C et al. In vivo modulation of Nogo-B attenuates neointima formation. Mol Ther 2008; 16: 1798-1804.
5. Akowuah EF, Gray C, Lawrie A, Sheridan PJ, Su CH, Bettinger T et al. Ultrasoundmediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model. Gene Therapy 2005; 12: 1154-1157.
6. George SJ, Lloyd CT, Angelini GD, Newby AC, Baker AH. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 2000; 101: 296-304.
7. George SJ, Wan S, Hu J, MacDonald R, Johnson JL, Baker AH. Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation 2011; 124(11 Suppl): S135-S142.
8. Coughlan L, Bradshaw AC, Parker AL, Robinson H, White K, Custers J et al. Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery. Mol Ther 2012; 20: 2268-2281.
9. Parker AL, Waddington SN, Buckley SM, Custers J, Havenga MJ, van Rooijen N et al. Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer. J Virol 2009; 83: 479-483.
10. Sprangers MC, Lakhai W, Koudstaal W, Verhoeven M, Koel BF, Vogels R et al. Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: Addressing preexisting immunity to vaccine and gene therapy vectors. J Clin Microbiol 2003; 41: 5046-5052.
11. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
12. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9: 1408-1412.
13. George SJ, Johnson JL, Angelini GD, Newby AC, Baker AH. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum Gene Ther 1998; 9: 867-877.
14. Greig JA, Buckley SM, Waddington SN, Parker AL, Bhella D, Pink R et al. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Mol Ther 2009; 17: 1683-1691.
15. Miwa T, Nonaka M, Okada N, Wakana S, Shiroishi T, Okada H. Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): Preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1. Immunogenetics 1998; 48: 363-371.
16. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H et al. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 2008; 132: 397-409.
17. McDonald RA, Hata A, MacLean MR, Morrell NW, Baker AH. MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovasc Res 2012; 93: 594-604.
18. Robertson KE, McDonald RA, Oldroyd KG, Nicklin SA, Baker AH. Prevention of coronary in-stent restenosis and vein graft failure: Does vascular gene therapy have a role? Pharmacol Ther 2012; 136: 23-34.
19. George SJ, Angelini GD, Capogrossi MC, Baker AH. Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis. Gene Therapy 2001; 8: 668-676.
20. Tomko RP, Xu R, Philipson L. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenovirus and group B coxsackieviruses. Proc Natl Acad Sci USA 1997; 94: 3352-3356.
21. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
22. Havenga MJ, Lemckert AA, Grimbergen JM, Vogels R, Huisman LG, Valerio D et al. Improved adenovirus vectors for infection of cardiovascular tissues. J Virol 2001; 75: 3335-3342.
23. Wang H, Li ZY, Liu Y, Persson J, Beyer I, Moller T et al. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med 2011; 17: 96-104.
24. Gaggar A, Shayakhmetov DM, Liszewski MK, Atkinson JP, Lieber A. Localization of regions in CD46 that interact with adenovirus. J Virol 2005; 79: 7503-7513.
25. Wang H, Liaw YC, Stone D, Kalyuzhniy O, Amiraslanov I, Tuve S et al. Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob. J Virol 2007; 81: 12785-12792.
26. Wang H, Liu Y, Li Z, Tuve S, Stone D, Kalyushniy O et al. In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46. J Virol 2008; 82: 10567-10579.
27. Augustin HG, Kozian DH, Johnson RC. Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 1994; 16: 901-906.
28. Zangani D, Darcy KM, Masso-Welch PA, Bellamy ES, Desole MS, Ip MM. Multiple differentiation pathways of rat mammary stromal cells in vitro: Acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation. Differentiation 1999; 64: 91-101.
29. Walters RW, Grunst T, Bergelson JM, Finberg RW, Welsh MJ, Zabner J. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem 1999; 274: 10219-10226.
30. Quax PH, Grimbergen JM, Lansink M, Bakker AH, Blatter MC, Belin D et al. Binding of human urokinase-type plasminogen activator to its receptor: Residues involved in species specificity and binding. Arterioscler Thromb Vasc Biol 1998; 18: 693-701.
31. Southgate K, Newby AC. Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. Atherosclerosis 1990; 82: 113-123.